Hier vindt u een chronologisch overzicht van wetenschappelijke publicaties in 2015-2011, gepubliceerd door de klinische onderzoeksgroepen die betrokken zijn bij ATHENA/SHM.


The impact of transient cART in early HIV infection on viral suppression and immunologic response in later treatment 
Pantazis N, Touloumi G, Meyer L, Olson A, Costagliola D, Kelleher AD, Lutsar I, Chaix ML, Fisher M, Moreno S, Porter K; CASCADE Collaboration in EuroCoord. 
AIDS. 2015 Dec 3. [Epub ahead of print] Abstract

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy 
Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G,Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration. 
Int J Epidemiol. 2015 Dec 31. pii: dyv295. [Epub ahead of print] Abstract

TB-HIV co-infection in the Netherlands: estimating prevalence and under-reporting in national registration databases using a capture-recapture analysis 
van Leth F, Evenblij K, Wit F, Kiers A, Sprenger H, Verhagen M, Hillebregt M, Kalisvaart N, Schimmel H, Verbon A 
J Epidemiol Community Health. 2015 Dec 23. pii: jech-2015-206680. doi: 10.1136/jech-2015-206680. [Epub ahead of print] Abstract

Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) from 2010 to 
The late presenters working group in COHERE in EuroCoord 
Eurosurveillance 2015 Nov 26;20(47) Article

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis 
Antiretroviral Therapy Cohort Collaboration (ART-CC), Canadian Observational Cohort Collaboration (CANOC), The UK Collaborative HIV Cohort Study (UK CHIC), the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE). 
AIDS 2015 Nov 10 [Epub ahead of print] Abstract

Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV+ persons with a normal baseline eGFR : A prospective international cohort study 
Mocroft A, Lundgren JD, Ross M, Fux CA, Reiss P, Moranne O, Morlat P, d'Arminio Montforte A, Kirk O, Ryom L for the Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) Study 
Lancet HIV 2015 Nov 16 Article

CD4 cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, gender and calendar time 
Cori A, Pickles M, van Sighem A, Gras L, Bezemer D, Reiss P, Fraser C. 
AIDS. 2015 Nov 28;29(18):2435-46 Abstract

Mortality in migrants living with HIV in western Europe (1997–2013): a collaborative cohort study 
The Migrants Working Group on behalf of COHERE in EuroCoord 
Lancet HIV Dec 2015;2(12):e540-e549 Abstract

Cerebral injury in perinatally HIV-infected children compared to matched healthy controls 
Cohen S, Caan MWA, Mutsaerts J, Scherpbier HJ, Kuijpers TW, Reiss P, Majoie CBLM, and Pajkrt D 
Neurology 2015 Nov 11[Epub ahead of print] Abstract

Health-related quality of life in perinatally HIV-infected children in the Netherlands 
Cohen S, Ter Stege JA, Weijsenfeld AM, van der Plas A, Kuijpers TW, Reiss P, Scherpbier HJ, Haverman L, Pajkrt D. 
AIDS Care. 2015 Oct;27(10):1279-88 Abstract

Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected? 
Boesecke C, Grint D, Soriano V, Lundgren JD, d'Arminio Monforte A, Mitsura VM, Chentsova N, Hadziosmanovic V, Kirk O, Mocroft A, Peters L, Rockstroh JK; EuroSIDA in EuroCoord. 
Liver Int. 2015 Nov;35(11):2384-91 Abstract

Does rapid HIV disease progression prior to cART hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? 
Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, Mussini C, Boufassa F, Costagliola D, Porter K, Blanco J, Del Amo J, Martinez-Picado J for CASCADE Collaboration in EuroCoord. 
AIDS. 2015 Nov;29(17):2323-33 Abstract

Effect of abacavir on sustained virologic response to HCV treatment in HIV/HCV co-infected patients, Cohere in Eurocoord. 
Hepatitis C- working group for COHERE in Eurocoord, Smit C, Arends J, Peters L, Montforte A, Dabis F, Zangerle R, Daikos G, Mussini C, Mallolas J, de Wit S, Zinkernagel A, Cosin J, Chene G, Raben D, Rockstroh J 
BMC Infect Dis. 2015 Nov 4;15:498. doi: 10.1186/s12879-015-1224-1. Abstract

Dispersion of the HIV-1 epidemic in men who have sex with men in the Netherlands: A combined mathematical model and phylogenetic analysis 
Bezemer D, Cori A, Ratmann O, van Sighem A, Hermanides HS, Dutilh BE, Gras L, Faria NR, van den Hengel R, Duits AJ, Reiss P, de Wolf F, Fraser A, ATHENA observational cohort 
PLoS Med 12(11):e1001898 Abstract

Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with eitherraltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143randomised trial. 
Bernardino JI, Mocroft A, Mallon PW, Wallet C, Gerstoft J, Russell C, Reiss P, Katlama C, De Wit S, Richert L, Babiker A, Buño A, Castagna A,Girard PM, Chene G, Raffi F, Arribas JR; NEAT001/ANRS143 Study Group. 
Lancet HIV. 2015 Nov;2(11):e464-73 Abstract

Acute Hepatitis C in the Netherlands; characteristics of the epidemic in 2014 
Hullegie SJ, van den Berk GE, Leyten EM, Arends JE, Lauw FN, van der Meer JT, Posthouwer D, van Eeden A, Koopmans PP, Richter C, van Kasteren ME, Kroon FP, Bierman WF, Groeneveld PH, Lettinga KD, Soetekouw R, Peters EJ, Verhagen DW, van Sighem AI, Claassen MA, Rijnders BJ 
Clin Microbiol Infect. 2015 Oct 16. pii: S1198-743X(15)00911-8 Abstract

Comparative effectiveness of strategies for antiretroviral treatment initiation in HIV-positive individuals in high-income countries: observational cohort study 
Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miro JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Toulomi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Perez-Hoyos S, Jarrin I, Jose S, Sabin C, Hernan MA, on behalf of the HIV-CAUSAL Collaboration 
The Lancet HIV 2015; 2(8):e335–e343 Abstract

Favourable SVR12 rates in boceprevir or telaprevir triple therapy in HIV/ HCV coinfected patients 
Arends JE, van der Meer JTM, Posthouwer D, Kortmann W, Brinkman K, van Assen S, Smit C, van der Valk M, van der Ende M, Schinkel J, Reiss P, Richter C, Hoepelman AIM, on behalf of Stichting HIV Monitoring/Nederlandse Vereniging van HIV Behandelaren Hepatitis Working Group, and the ATHENA national observational HIV cohort
Neth J Med 2015 Aug;73(7):324-330 Abstract

Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals 
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; ATHENA national observational cohort and the MOSAIC study 
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):536-42 Abstract

Risk factors for sexual transmission of hepatitis C virus among human immunodeficiency virus-infected men who have sex with men: a case-control study 
Vanhommerig JW, Lambers FA, Schinkel J, Geskus RB, Arends JE, van de Laar TJ, Lauw FN, Brinkman K, Gras L, Rijnders BJ, van der Meer JT,Prins M; MOSAIC (MSM Observational Study of Acute Infection With Hepatitis C) Study Group, van der Meer JT, Molenkamp R, Mutschelknauss M, Nobel HE,Reesink HW, Schinkel J, van der Valk M, van den Berk GE, Brinkman K, Kwa D, van der Meche N, Toonen A, Vos D, van Broekhuizen M, Lauw FN, Mulder JW,Arends JE, van Kessel A, de Kroon I, Boonstra A, van der Ende ME, Hullegie S, Rijnders BJ, van de Laar TJ, Gras L, Smit C, Lambers FA, Prins M,Vanhommerig JW, van der Veldt W. 
Open Forum Infect Dis. 2015 Aug 6;2(3):ofv115  Abstract

Impact of male circumcision among heterosexual HIV cases: comparisons between three low HIV prevalence countries 
Chemtob D, Op de Coul E, van Sighem A, Mor Z, Cazein F, Semaille C 
Isr J Health Policy Res. 2015 Aug 4;4:36 Abstract

Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study. 
Achhra AC, Mocroft A, Reiss P, Sabin C, Ryom L, de Wit S, Smith CJ, d'Arminio Monforte A, Phillips A, Weber R, Lundgren J, Law MG; D:A:D StudyGroup. 
HIV Med. 2015 Jul 28. doi: 10.1111/hiv.12294. [Epub ahead of print] Abstract

Poorer cognitive performance in perinatally HIV-infected children versus healthy socioeconomically matched controls. 
Cohen S, Ter Stege JA, Geurtsen GJ, Scherpbier HJ, Kuijpers TW, Reiss P, Schmand B, Pajkrt D 
Clin Infect Dis. 2015 Apr 1;60(7):1111-9. Abstract

Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy. 
Zhang S, van Sighem A, Kesselring A, Gras L, Prins JM, Hassink E, Kauffmann R, Richter C, de Wolf F, Reiss P; ATHENA national observational HIV cohort study 
HIV Med. 2015 May;16(5):265-72 Abstract

Anal cancer in the HIV positive population: Slowly declining incidence after a decade of cART 
Richel O, Van der Zee R , Smit C, De Vries H, Prins J 
J Acquir Immune Defic Syndr. 2015 Aug 15;69(5):602-5 Abstract

Estimating HIV incidence, time to diagnosis, and the undiagnosed HIV epidemic using routine surveillance data 
Sighem AV, Nakagawa F, Angelis D, Quinten C, Bezemer D, Coul EO, Egger M, Wolf F, Fraser C, Phillips A 
Epidemiology. 2015 Jul 21. [Epub ahead of print] Abstract

Long-term changes of subcutaneous fat mass in HIV-infected children on antiretroviral therapy: A retrospective analysis of longitudinal data from two pediatric HIV cohorts 
Cohen S, Innes S, Geelen SP, Wells JC, Smit C, Wolfs TF, van Eck-Smit BL, Kuijpers TW, Reiss P, Scherpbier HJ, Pajkrt D, Bunders MJ 
PLoS One. 2015 Jul 6;10(7):e0120927 Abstract

Future challenges for clinical care of an ageing population infected with HIV: a modelling study. 
Smit M, Brinkman K, Geerlings S, Smit C, Thyagarajan K, Sighem A v, de Wolf F, Hallett TB; ATHENA observational cohort. 
Lancet Infect Dis. 2015 Jul;15(7):810-8. Abstract

HIV resistance testing and detected drug resistance in Europe. 
Schultze A, Phillips AN, Paredes R, Battegay M, Rockstroh JK, Machala L, Tomazic J, Girard PM, Januskevica I, Gronborg-Laut K, Lundgren JD, Cozzi-Lepri A;EuroSIDA in EuroCOORD 
AIDS. 2015 Jul 17;29(11):1379-89.  Abstract

Retinal structure and function in perinatally HIV-infected and cART-treated children: A matched case-control study 
Demirkaya N, Cohen S, Wit FW, Abramoff MD, Schlingemann RO, Kuijpers TW, Reiss P, Pajkrt D, Verbraak FD. 
Invest Ophthalmol Vis Sci. 2015 Jun 1;56(6):3945-54 Abstract

An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study 
Friis-Møller N, Ryom L, Smith C, Weber R, Reiss P, Dabis F, De Wit S, Monforte AD, Kirk O, Fontas E, Sabin C, Phillips A, Lundgren J, Law M;D:A:D study group 
Eur J Prev Cardiol. 2015 Apr 16 Abstract

Low mother-to-child-transmission rate of Hepatitis C virus in cART treated HIV-1 infected Mothers 
Snijdewind I, Smit C, Schutten M, Nellen FJB, Kroon FP, Reiss P, van der Ende ME 
J Clin Virol. 2015 Jul;68:11-5. Abstract

GBD 2013 and HIV incidence in high income countries 
Supervie V, Archibald CP, Costagliola D, Delpech V, Hall HI, Lot F, van Sighem A, Wilson DP.
Lancet. 2015 Mar 28;385(9974):1177. doi: 10.1016/S0140-6736(15)60626-2. Abstract

Use of surveillance data on HIV diagnoses with HIV-related symptoms to estimate the number of people living with undiagnosed HIV in need of antiretroviral therapy. 
Lodwick RK, Nakagawa F, van Sighem A, Sabin CA, Phillips AN 
PLoS One. 2015 Mar 13;10(3):e0121992 Abstract

Injection drug use and hepatitis C as risk factors for mortality in HIV-infected individuals: The Antiretroviral Therapy Cohort Collaboration 
May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ,Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA 
J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):348-54 Abstract

Changing patterns of undiagnosed HIV infection in the Netherlands: Who benefits most from intensified HIV test and treat policies? 
Op de Coul EL, Schreuder I, Conti S, van Sighem A, Xiridou M, Van Veen MG, Heijne JC 
PLoS One. 2015 Jul 17;10(7):e0133232 Abstract

Liver-related death among HIV/hepatitis C virus-co-infected individuals: implications for the era of directly acting antivirals. 
Grint D, Peters L, Rockstroh JK, Rakmanova A, Trofimova T, Lacombe K, Karpov I, Galli M, Domingo P, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord. 
AIDS. 2015 Jun 19;29(10):1205-15.  Abstract

Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study 
Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L; D:A:D study group; Royal Free Hospital Clinic Cohort; INSIGHT study group; SMART study group; ESPRIT study group. 
PLoS Med. 2015 Mar 31;12(3):e1001809. doi: 10.1371/journal.pmed.1001809. eCollection 2015.Abstract

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. 
Antiretroviral Therapy Cohort Collaboration (ART-CC), Vandenhende MA, Ingle S, May M, Chene G, Zangerle R, Van Sighem A, Gill MJ, Schwarze-Zander C,Hernandez-Novoa B, Obel N, Kirk O, Abgrall S, Guest J, Samji H, D'Arminio Monforte A, Llibre JM, Smith C, Cavassini M, Burkholder GA, Shepherd B, Crane HM,Sterne J, Morlat P. 
AIDS. 2015 Jan 28;29(3):373-83. doi: 10.1097/QAD.0000000000000544. Abstract

Cancer risk and use of protease inhibitor or non-nucleoside reverse transcriptase inhibitor based combination antiretroviral therapy: the D:A:D study 
Bruyand M, Ryom L, Shepherd L, Fatkenheuer G, Grulich A, Reiss P, de Wit S, D Arminio Monforte A, Furrer H, Pradier C, Lundgren J, Sabin C; D:A:D studygroup. 
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):568-77. doi: 10.1097/QAI.0000000000000523.Abstract

Efficacy of etravirine combined with darunavir or other ritonavir-boosted protease inhibitors in HIV-1-infected patients: an observational study using pooled European cohort data. 
Vingerhoets J, Calvez V, Flandre P, Marcelin AG, Ceccherini-Silberstein F, Perno CF, Mercedes Santoro M, Bateson R, Nelson M, Cozzi-Lepri A, Grarup J,Lundgren J, Incardona F, Kaiser R, Sonnerborg A, Clotet B, Paredes R, Günthard HF, Ledergerber B, Hoogstoel A, Nijs S, Tambuyzer L, Lavreys L, Opsomer M;Etravirine Cohort Study Group. 
HIV Med. 2015 May;16(5):297-306.  Abstract

Boosted lopinavir vs. boosted atazanavir-containing regimens and immunologic, virologic and clinical outcomes: A prospective study of HIV-infected individuals in high-income countries  
The HIV-CAUSAL Collaboration. 
Clin Infect Dis. 2015 Jan 6. pii: ciu1167. [Epub ahead of print] Abstract

Diminished impact of ethnicity as a risk factor for chronic kidney disease in the current HIV treatment era 
Schoffelen AF, Smit C, van Lelyveld SF, Vogt L, Bauer MP, Reiss P, Hoepelman AI, Barth RE; on behalf of the ATHENA national observational HIV cohort.
J Infect Dis. 2015 Jan 18. pii: jiv026. [Epub ahead of print] Abstract

Multivariate normative comparison, a novel method for more reliably detecting cognitive impairment in HIV infection 
Su T, Schouten J, Geurtsen GJ, Wit FW, Stolte IG, Prins M, Portegies P, Caan MW, Reiss P, Majoie CB, Schmand BA; the AGEhIV Cohort Study Group.
AIDS. 2015 Jan 14. [Epub ahead of print] Abstract

Country of Birth Does Not Influence Long-term Clinical, Virologic, and Immunological Outcome of HIV-Infected Children Living in the Netherlands: A Cohort Study Comparing Children Born in the Netherlands With Children Born in Sub-Saharan Africa 
Cohen S, van Bilsen WP, Smit C, Fraaij PL, Warris A, Kuijpers TW, Geelen SP, Wolfs TF, Scherpbier HJ, van Rossum AM, Pajkrt D.
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):178-85. doi: 10.1097/QAI.0000000000000431.Abstract


Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. 
IeDEA and ART Cohort Collaborations
J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):e8-e16. doi: 10.1097/QAI.0b013e3182a39979.Abstract

Long-term Effectiveness of Combination Antiretroviral Therapy and Prevalence of HIV Drug Resistance in HIV-1-infected Children and Adolescents in Rwanda. 
Mutwa PR, Boer KR, Rusine J, Muganga N, Tuyishimire D, Schuurman R, Reiss P, Lange JM, Geelen SP.
Pediatr Infect Dis J. 2014 Jan;33(1):63-9. doi: 10.1097/INF.0b013e31829e6b9f. Abstract

Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. 
Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, Morlat P, Moranne O, Smith C, El-Sadr W, Law M, Lundgren JD.
AIDS. 2014 Jan 14;28(2):187-99. doi: 10.1097/QAD.0000000000000042. Abstract

Blunted Response to Combination Antiretroviral Therapy in HIV Elite Controllers: An International HIV Controller Collaboration. 
Boufassa F, Lechenadec J, Meyer L, Costagliola D, Hunt PW, Pereyra F, Deeks S, Pancino G, Taulera O, Lichterfeld M, Delobel P, Saez-Cirion A, Lambotte O; ANRS CO HIV Controllers Cohort, the Cascade Collaboration in Eurocoord, the SCOPE Cohort and the International HIV Controllers Study.
PLoS One. 2014 Jan 17;9(1):e85516. doi: 10.1371/journal.pone.0085516. eCollection 2014.Abstract

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration. 
Olson AD, Meyer L, Prins M, Thiebaut R, Gurdasani D, Guiguet M, Chaix ML, Amornkul P, Babiker A, Sandhu MS, Porter K; for C.A.S.C.A.D.E. Collaboration in EuroCoord.
PLoS One. 2014 Jan 28;9(1):e86719. doi: 10.1371/journal.pone.0086719. eCollection 2014.Abstract

Prognostic value of vitamin D level for all-cause mortality, and association with inflammatory markers, in HIV-infected persons. 
Shepherd L, Souberbielle JC, Bastard JP, Fellahi S, Capeau J, Reekie J, Reiss P, Blaxhult A, Bickel M, Leen C, Kirk O, Lundgren JD, Mocroft A, Viard JP; On behalf of EuroSIDA in EuroCOORD.
J Infect Dis. 2014 Jul 15;210(2):234-43. doi: 10.1093/infdis/jiu074. Epub 2014 Feb 3. Abstract

Long-term mortality in HIV positive individuals virally suppressed for more than three years with incomplete CD4 recovery. 
Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, Monforte AD, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N; The Antiretroviral Therapy Cohort Collaboration (ART-CC) and the Collaboration of Observational HIV Research Europe (COHERE) in EuroCoord.
Clin Infect Dis. 2014 May;58(9):1312-21. doi: 10.1093/cid/ciu038. Epub 2014 Jan 22. Abstract

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study 
Kamara DA, Ryom L, Ross M, Kirk O, Reiss P, Morlat P, Moranne O, Fux CA, Mocroft A, Sabin C, Lundgren JD, Smith CJ; D:A:D study Group.
BMC Nephrol. 2014 Mar 25;15(1):51. doi: 10.1186/1471-2369-15-51 Abstract

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy 
Revell A, Boyd M, Wang D, Emery S, Gazzard B, Reiss P, van Sighem A, Montaner J, Lane H, Larder B.
HIV Med. 2014 Aug;15(7):442-8. doi: 10.1111/hiv.12156. Epub 2014 Apr 15. Abstract

High rate of hepatitis C virus (HCV) recurrence in HIV-infected individuals with spontaneous HCV RNA clearance. 
Peters L, Mocroft A, Soriano V, Rockstroh J, Kirkby N, Reiss P, Katlama C, Zakharova N, Flisiak R, Lundgren J; for EuroSIDA in EuroCoord
HIV Med. 2014 May 11. doi: 10.1111/hiv.12160. [Epub ahead of print] Abstract

Antiretroviral penetration into the CNS and incidence of AIDS-defining neurologic conditions 
Caniglia EC, Cain LE, Justice A, Tate J, Logan R, Sabin C, Winston A, van Sighem A, Miro JM, Podzamczer D, Olson A, Arribas JR, Moreno S, Meyer L, Del Romero J, Dabis F, Bucher HC, Wandeler G, Vourli G, Skoutelis A, Lanoy E, Gasnault J, Costagliola D, Hernán MA; HIV-CAUSAL Collaboration. 
Neurology. 2014 Jul 8;83(2):134-41. doi: 10.1212/WNL.0000000000000564. Epub 2014 Jun 6. PubMed PMID: 24907236. Abstract

Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel 
Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P, Saag MS, Thomas DL, Jacobsen DM, Volberding PA.
JAMA. 2014 Jul 23-30;312(4):410-25. doi: 10.1001/jama.2014.8722. Abstract

Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients. 
Ingle SM, May MT, Gill MJ, Mugavero MJ, Lewden C, Abgrall S, Fätkenheuer G, Reiss P7, Saag MS, Manzardo C, Grabar S, Bruyand M, Moore D, Mocroft A, Sterling TR, D'Arminio Monforte A, Hernando V, Teira R, Guest J, Cavassini M, Crane HM, Sterne JA; Antiretroviral Therapy Cohort Collaboration.
Clin Infect Dis. 2014 Jul 15;59(2):287-97. doi: 10.1093/cid/ciu261. Epub 2014 Apr 24. Abstract

Sex differences in overall and cause-specific mortality among HIV-infected adults on antiretroviral therapy in Europe, Canada and the US. 
The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Antivir Ther. 2014 Mar 27. doi: 10.3851/IMP2768. [Epub ahead of print] Abstract

Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations. 
Petoumenos K, Reiss P, Ryom L, Rickenbach M, Sabin C, El-Sadr W, d'Arminio Monforte A, Phillips A, De Wit S, Kirk O, Dabis F, Pradier C, Lundgren J, Law M; D:A:D study group.
HIV Med. 2014 May 19. doi: 10.1111/hiv.12162. [Epub ahead of print] Abstract

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe. 
Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P, Jevtovic D, Machala L, Zangerle R, Mocroft A, Van Lunzen J; EuroSIDA in EuroCoord.
PLoS One. 2014 Jan 31;9(1):e87160. doi: 10.1371/journal.pone.0087160. eCollection 2014.Abstract

A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe. 
Mocroft A, Reiss P, Rakhmanova A, Banhegyi D, Phillips AN, De Wit S, Ristola M, Lundgren JD, Grarup J, Kirk O; for EuroSIDA in EuroCOORD.
Infection. 2014 Aug;42(4):757-62. doi: 10.1007/s15010-014-0630-4. Epub 2014 Jun 6. Abstract

Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals. 
Natural History Project Working Group for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord.
AIDS. 2014 Jun 1;28(9):1351-6. doi: 10.1097/QAD.0000000000000224. Abstract

'Let's Talk about Sex': A Qualitative Study of Rwandan Adolescents' Views on Sex and HIV. 
Van Nuil JI, Mutwa P, Asiimwe-Kateera B, Kestelyn E, Vyankandondera J, Pool R, Ruhirimbura J, Kanakuze C, Reiss P, Geelen SP, van de Wijgert JH, Boer KR.
PLoS One. 2014 Aug 5;9(8):e102933. doi: 10.1371/journal.pone.0102933. eCollection 2014.Abstract

HIV-1 transmission networks amongst men having sex with men and heterosexuals in Kenya  
Bezemer D, Faria NR, Hassan AS, Hamers RL, Mutua G, Anzala O, Mandaliya KN, Cane PA, Berkley JA, Rinke de Wit TF, Wallis CL, Graham SM, Price MA, Coutinho R, Sanders EJ.
AIDS Res Hum Retroviruses. 2014 Feb;30(2):118-26. doi: 10.1089/AID.2013.0171. Epub 2013 Sep 17. Abstract

A comparison of estimated glomerular filtration rates using Cockcroft-Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection 
Mocroft A, Ryom L, Reiss P, Furrer H, D'Arminio Monforte A, Gatell J, de Wit S, Beniowski M, Lundgren J, Kirk O; for EuroSIDA in EuroCOORD. 
HIV Med. 2014 Mar;15(3):144-52. doi: 10.1111/hiv.12095. Epub 2013 Oct 3. Abstract

An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes 
Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JS, Lane HC, Larder BA; on behalf of the RDI Study Group.
J Antimicrob Chemother. 2014 Apr;69(4):1104-10. doi: 10.1093/jac/dkt447. Epub 2013 Nov 24.Abstract

A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. 
Langebeek N, Sprenger H, Gisolf E, Reiss P, Sprangers M, Legrand J, Richter C, Nieuwkerk P.
HIV Med. 2014 May;15(5):286-90. doi: 10.1111/hiv.12112. Epub 2013 Nov 11. Abstract

Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). 
May MT, Ingle SM, Costagliola D, Justice AC, de Wolf F, Cavassini M, D'Arminio Monforte A, Casabona J, Hogg RS, Mocroft A, Lampe FC, Dabis F, Fätkenheuer G, Sterling TR, del Amo J, Gill MJ, Crane HM, Saag MS, Guest J, Brodt HR, Sterne JA; Antiretroviral Cohort Collaboration.
Int J Epidemiol. 2014 Jun;43(3):691-702. doi: 10.1093/ije/dyt010. Epub 2013 Apr 18. Abstract

Trends in underlying causes of death in people with HIV from 1999-2011 (D:A:D): a multicohort collaboration. 
CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, S de Wit, M Law, W el Sadr, O Kirk, N Friis-Moller, Ad Monforte, AN Phillips, CA Sabin, JD Lundgren, D:A:D Study Group
Lancet. 2014 Jul 19;384(9939):241-8. doi: 10.1016/S0140-6736(14)60604-8. Abstract

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies. 
Boulle A, Schomaker M, May MT, Hogg RS, Shepherd BE, Monge S, Keiser O, Lampe FC, Giddy J, Ndirangu J, Garone D, Fox M, Ingle SM, Reiss P, Dabis F, Costagliola D, Castagna A, Ehren K, Campbell C, Gill MJ, Saag M, Justice AC, Guest J, Crane HM, Egger M, Sterne JA. 
PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014.Abstract

Sexually transmitted infections, including HIV, in the Netherlands in 2013 
van Aar F, Koedijk FDH, van den Broek IVF, Op de Coul ELM, Soetens LC, Woestenberg PJ, Heijne JCM, van Sighem AI, Nielen MMJ, van Benthem BHB
RIVM Rapport 150002005 Abstract

Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries 
HIV-CAUSAL Collaboration
AIDS. 2014 Oct 23;28(16):2461-73. doi: 10.1097/QAD.0000000000000456 Abstract

Increased Virological Failure in Naive HIV-1 Patients Taking Lamivudine Compared to Emtricitabine in Combination with Tenofovir and Efavirenz or Nevirapine in the Dutch Nationwide ATHENA Cohort 
Rokx C, Fibriani A, van de Vijver DA, Verbon A, Schutten M, Gras L, Rijnders BJ; On behalf of the ATHENA National Observational Cohort.
Clin Infect Dis. 2014 Oct 1. pii: ciu763. [Epub ahead of print] Abstract

Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults 
Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; for the Efavirenz, Obesity Project Team the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. 
AIDS. 2014 Nov 25 Abstract

Estimating HIV incidence from case-report data: method and an application in Colombia 
Vesga JF, Cori A, van Sighem A, Hallett TB 
AIDS. 2014 Nov;28 Suppl 4:S489-96. doi: 10.1097/QAD.0000000000000466 Abstract

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America: The ART Cohort Collaboration 
Helleberg M, May MT, Ingle SM, Dabis F, Reiss P, Fätkenheuer G, Costagliola D, d'Arminio A, Cavassini M, Smith C, Justice AC, Gill J, Sterne JA, Obel N. 
AIDS. 2014 Nov 25 Abstract

Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: The AGEhIV Cohort Study. 
Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, Prins M, Reiss P; AGEhIV Cohort Study Group.
Clin Infect Dis. 2014 Dec 15;59(12):1787-97 Abstract

A clinically useful risk-score for chronic kidney disease in HIV infection. 
Mocroft A, Lundgren J, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Heuhaus J, Fux C, Moranne O, Morlat P, Johnson M, Ryom L; Data on Adverse Events (D:A:D) study group, the Royal Free Hospital Clinic Cohort and the INSIGHT study group.
J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19514 Abstract

Changes in HIV RNA and CD4 cell count following acute HCV infection in chronically HIV-infected individuals 
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; for the ATHENA national observational cohort and the MOSAIC study.
J Acquir Immune Defic Syndr. 2014 Dec 31. [Epub ahead of print] Abstract

Changes in HIV RNA and CD4 cell count following acute HCV infection in chronically HIV-infected individuals 
Gras L, de Wolf F, Smit C, Prins M, van der Meer JT, Vanhommerig JW, Zwinderman AH, Schinkel J, Geskus RB; for the ATHENA national observational cohort and the MOSAIC study.
J Acquir Immune Defic Syndr. 2014 Dec 31. [Epub ahead of print] Abstract

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy 
May MT, Gompels M, Delpech V, Porter K, Orkin C, Kegg S, Hay P, Johnson M, Palfreeman A, Gilson R, Chadwick D, Martin F, Hill T, Walsh J, Post F, Fisher M, Ainsworth J, Jose S, Leen C, Nelson M, Anderson J, Sabin C; UK Collaborative HIV Cohort (UK CHIC) Study.
AIDS. 2014 May 15;28(8):1193-202. doi: 10.1097/QAD.0000000000000243. Abstract

Prognosis of children with HIV-1 infection starting antiretroviral therapy in Southern Africa: a collaborative analysis of treatment programs 
Davies MA, May M, Bolton-Moore C, Chimbetete C, Eley B, Garone D, Giddy J, Moultrie H, Ndirangu J, Phiri S, Rabie H, Technau KG, Wood R, Boulle A, Egger M, Keiser O; IeDEA Southern Africa Collaboration.
Pediatr Infect Dis J. 2014 Jun;33(6):608-16. doi: 10.1097/INF.0000000000000214. Abstract

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE inEuroCoord
Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS. 2014 Sep 24;28(15):2297-306. doi: 10.1097/QAD.0000000000000410. Abstract

Post-licensing safety of fosamprenavir in HIV-infected children in Europe 
Judd A, Duong T, Galli L, Goetghebuer T, Ene L, Julian AN, Ramos Amador JT, Pimenta JM, Thorne C, Giaquinto C; European Pregnancy and Paediatric HIV Cohort Collaboration (EPPICC) study group in EuroCoord.
Pharmacoepidemiol Drug Saf. 2014 Mar;23(3):321-5. Abstract

Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe 
Podlekareva DN, Panteleev AM, Grint D, Post FA, Miro JM, Bruyand M, Furrer H, Obel N, Girardi E, Vasilenko A, Losso MH, Arenas-Pinto A, Caylá J, Rakhmanova A, Zeltina I, Werlinrud AM, Lundgren JD, Mocroft A, Kirk O; HIV/TB study group.
Eur Respir J. 2014 Jan;43(1):166-77. doi: 10.1183/09031936.00138712. Epub 2013 Jun 13.Abstract

 Increased incidence of antiretroviral drug discontinuation among patients with viremic HCV coinfection and high hyaluronic acid, a marker of liver fibrosis 
Grint D1, Peters L, Rockstroh JK, de Wit S, Mitsura VM, Knysz B, Pedersen C, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.
AIDS. 2014 Feb 20;28(4):577-87. doi: 10.1097/QAD.0000000000000069. Abstract

Deteriorating renal function and clinical outcomes in HIV-positive persons 
Mocroft A, Ryom L, Begovac J, Monforte AD, Vassilenko A, Gatell J, Florence E, Ormaasen V, Kirk O, Lundgren JD; EuroSIDA in EuroCOORD.
AIDS. 2014 Mar 13;28(5):727-37. doi: 10.1097/QAD.0000000000000134. Abstract

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective 
Peters L, Mocroft A, Lundgren J, Grint D, Kirk O, Rockstroh J.
BMC Infect Dis. 2014;14 Suppl 6:S13. doi: 10.1186/1471-2334-14-S6-S13. Epub 2014 Sep 19.Abstract

Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord 
Socio-economic Inequalities and HIV Writing Group for Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
AIDS. 2014 Sep 24;28(15):2297-306. doi: 10.1097/QAD.0000000000000410. Abstract

The effects of HIV-1 subtype and ethnicity on CD4 decline in antiretroviral naïve patients: a Canadian-European collaborative cohort study 
Klein MB, Young J, Dunn D, Ledergerber B, Sabin C, Cozzi-Lepri A, Dabis F, Harrigan R, Tan DH, Walmsley S, Gill J, Cooper C, Scherrer AU,Mocroft A, Hogg RS, Smaill F; Canadian−European Clade Collaboration. 
CMAJ Open. 2014 Oct 1;2(4):E318-29. doi: 10.9778/cmajo.20140017. eCollection 2014. Abstract


Symptomatic illness and low CD4 cell count at HIV seroconversion as markers of severe primary HIV infection 
Lodi S, Fisher M, Phillips A, De Luca A, Ghosn J, Malyuta R, Zangerle R, Moreno S, Vanhems P, Boufassa F, Guiguet M, Porter K, for CASCADE Collaboration in EuroCoord
PLoS One. 2013 Nov 14;8(11):e78642. doi: 10.1371/journal.pone.0078642. eCollection 2013.Abstract

Associations between immune depression and cardiovascular events in HIV infection. 
Sabin CA, Ryom L, De Wit S, Mocroft A, Phillips AN, Worm SW, Weber R, D'Arminio Monforte A, Reiss P, Kamara D, El-Sadr W, Pradier C, Dabis F, Law M,Lundgren J; D:A:D Study Group.
AIDS. 2013 Nov 13;27(17):2735-48. doi: 10.1097/01.aids.0000432457.91228.f3. Abstract

Gradually decreasing anal cancer incidence in the HIV+ population in the Netherlands after a decade of cART 
Richel O, Van der Zee RP, Smit C, De Vries HJ, Prins JM.
Sex Health. 2013 Nov;10(6):586. doi: 10.1071/SHv10n6ab33. Abstract

Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. 
Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, D Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA.
BMC Infect Dis. 2013 Oct 9;13(1):471. [Epub ahead of print] Abstract

The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression 
Gijsbers EF, van Sighem A, Harskamp AM, Welkers MR, de Wolf F, Brinkman K, Prins JM, Schuitemaker H, van 't Wout AB, Kootstra NA.
PLoS One. 2013 Oct 1;8(10):e76255. Abstract

Changes in First-Line cART Regimens and Short-Term Clinical Outcome between 1996 and 2010 in The Netherlands. 
Smit M, Smit C, Geerlings S, Gras L, Brinkman K, Hallett TB, de Wolf F; Athena Observational Cohort.
PLoS One. 2013 Sep 30;8(9):e76071. doi: 10.1371/journal.pone.0076071. Abstract

How effectively can HIV phylogenies be used to measure heritability? 
G. Shirreff, S. Alizon, A. Cori, H.F. Günthard, O. Laeyendecker, A. van Sighem, D. Bezemer and C. Fraser
EMPH (2013) 2013 (1): 209-224. doi: 10.1093/emph/eot019. First published online: September 13, 2013 Abstract

Age biases in a large HIV and sexual behaviour-related internet survey among MSM 
Marcus U, Hickson F, Weatherburn P, Schmidt AJ.
BMC Public Health. 2013 Sep 10;13(1):826. [Epub ahead of print] Abstract

Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). 
Mocroft A, Lundgren JD, Sabin ML, Monforte AD, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCoord.
PLoS Med. 2013 Sep;10(9):e1001510. Epub 2013 Sep 3. Abstract

Missed Opportunities Among HIV-Positive Women to Control Viral Replication During Pregnancy and to Have a Vaginal Delivery 
Aebi-Popp K, Mulcahy F, Glass TR, Rudin C, Martinez de Tejada B, Bertisch B, Fehr J, Grawe C, Scheibner K, Rickenbach M, Hoesli I, Thorne C; for the European Collaborative Study in EuroCoord and the Swiss Mother & Child HIV Cohort Study.
J Acquir Immune Defic Syndr. 2013 Sep 1;64(1):58-65. Abstract

The effect of statin therapy on pneumonia in an HIV-infected population in the Netherlands 
Janssen NE, van Lelyveld SF, Hoepelman AI, Gras L, Groenwold RH, Oosterheert JJ.
J Infect. 2013 Sep;67(3):238-41. doi: 10.1016/j.jinf.2013.04.011. Epub 2013 Apr 19. Abstract

Advanced chronic kidney disease, end-stage renal disease and renal death among HIV-positive individuals in Europe 
Ryom L, Kirk O, Lundgren J, Reiss P, Pedersen C, De Wit S, Buzunova S, Gasiorowski J, Gatell J, Mocroft A; EuroSIDA in EuroCoord.
HIV Med. 2013 Sep;14(8):503-8. doi: 10.1111/hiv.12038. Epub 2013 Apr 16. Abstract

The effect of efavirenz versus nevirapine-containing regimens in the HIV-CAUSAL Collaboration: reply to Llibre and Podzamczer and additional results 
Cain, Lauren E.; Hernán, Miguel A.; on behalf of the HIV-CAUSAL Collaboration. 
AIDS. 2013 Aug 24;27(13):2169-2170. Abstract

Loss to follow-up and mortality rates in HIV-1 positive patients in Curaçao before and after the start of combined antiretroviral therapy 
Hermanides H, Holman R, Gras L, Winkel C, Gerstenbluth I, de Wolf F, Duits A.
AIDS Res Hum Retroviruses. 2013 Aug 31. [Epub ahead of print] Abstract

The Incidence of AIDS-Defining Illnesses at a Current CD4 Count >=200 Cells/?L in the Post-Combination Antiretroviral Therapy Era 
Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD; for the Opportunistic Infections Working Group on behalf of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study in EuroCOORD.
Clin Infect Dis. 2013 Aug 6. [Epub ahead of print] Abstract

Association between ALT level and the rate of cardio/cerebrovascular events in HIV-positive individuals: The D: A: D Study 
Sabin CA, Ryom L, Kovari H, Kirk O, de Wit S, Law M, Reiss P, Dabis F, Pradier C, El-Sadr W, Monforte Ad, Kamara D, Phillips AN, Lundgren JD.
J Acquir Immune Defic Syndr. 2013 Aug 1;63(4):456-63. doi: 10.1097/QAI.0b013e318291cd29.Abstract

Does hepatitis C viremia or genotype predict the risk of mortality in individuals coinfected with HIV? 
Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte Ad, Beniowski M, Losso MH, Kirk O, Kupfer B, Mocroft A; for EuroSIDA in EuroCoord.
J Hepatol. 2013 Aug;59(2):213-20. doi: 10.1016/j.jhep.2013.04.005. Epub 2013 Apr 11. Abstract

Natural History of HIV control since seroconversion 
Madec Y, Boufassa F, Porter K, Prins M, Sabin C, Monforte AD, Amornkul P, Bartmeyer B, Sannes M, Venet A, Lambotte O, Meyer L; on behalf of the CASCADE Collaboration in Eurocoord.
AIDS. 2013 Aug 1. [Epub ahead of print] Abstract

Virologic and Immunologic Response to cART by HIV-1 Subtype in the CASCADE Collaboration 
Touloumi G, Pantazis N, Chaix ML, Bucher HC, Zangerle R, Kran AM, Thiebaut R, Masquelier B, Kucherer C, Monforte Ad, Meyer L, Porter K; for CASCADE Collaboration in EuroCoord.
PLoS One. 2013 Jul 30;8(7):e71174. doi: 10.1371/journal.pone.0071174. Print 2013. Abstract

Stability of hepatitis C virus (HCV) RNA levels among interferon-naïve HIV/HCV-coinfected individuals treated with combination antiretroviral therapy 
Grint D, Peters L, Reekie J, Soriano V, Kirk O, Knysz B, Suetnov O, Lazzarin A, Ledergerber B, Rockstroh J, Mocroft A; EuroSIDA in EuroCoord. 
HIV Med. 2013 Jul;14(6):370-8. doi: 10.1111/hiv.12033. Epub 2013 Mar 27. Abstract

Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996-2012. 
Cohen S, Smit C, van Rossum AM, Fraaij PL, Wolfs TF, Geelen SP, Schölvinck EH, Warris A, Scherpbier HJ, Pajkrt D; on behalf of the Dutch paediatric HIV study group.
AIDS. 2013 Jul 9. [Epub ahead of print] Abstract

Performance of parametric survival models under non-random interval censoring: a simulation study 
Pantazis N, Kenward MG, Touloumi G, on behalf of CASCADE Collaboration in EuroCoord
Computational Statistics & Data Analysis, Volume 63, July 2013; 16-30. DOI: 10.1016/j.csda.2013.01.014 Abstract

Sexually transmitted infections, including HIV, in the Netherlands in 2012 
Soetens LC, Koedijk FDH, van den Broek IVF, Vriend HJ, Op de Coul ELM, van Aar F, van Sighem AI, Stirbu-Wagner I, van Benthem BHB.
RIVM report number: 150002003/2013; ISBN 978-90-6960-264-6 Article

Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients. 
Peters L, Mocroft A, Soriano V, Rockstroh J, Rauch A, Karlsson A, Knysz B, Pradier C, Zilmer K, Lundgren JD; for EuroSIDA in EuroCoord.
PLoS One. 2013 May 27;8(5):e64283. doi: 10.1371/journal.pone.0064283. Print 2013. Abstract

Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM? 
Gras L, Geskus RB, Jurriaans S, Bakker M, van Sighem A, Bezemer D, Fraser C, Prins JM, Berkhout B; Frank de Wolf1,4 for the ATHENA national observational cohort.
PLoS One. 2013 May 27;8(5):e64437. doi: 10.1371/journal.pone.0064437. Print 2013. Abstract

Higher rates of AIDS during the first year of antiretroviral therapy among migrants: the importance of tuberculosis 
Antiretroviral Therapy Cohort Collaboration (ART-CC), Shepherd BS, Jenkins CA, Parrish DD, Glass TR, Cescon A, Masabeu A, Chene G, de Wolf F, Crane HM, Jarrin I, Gill J, del Amo J, Abgrall S, Khaykin P, Lehmann C, Ingle SM, May MT, Sterne JA, Sterling TR.
AIDS. 2013 May 15;27(8):1321-9. doi: 10.1097/QAD.0b013e32835faa95. Abstract

Severe bacterial non-AIDS infections in HIV-positive persons: incidence rates and risk factors 
Søgaard OS, Reekie J, Ristola M, Jevtovic D, Karpov I, Beniowski M, Servitskiy S, Domingo P, Reiss P, Mocroft A, Kirk O.
J Infect. 2013 May;66(5):439-46. doi: 10.1016/j.jinf.2012.12.012. Epub 2013 Jan 24. Abstract

Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands; host or environmental factors? 
Schoffelen AF, van Lelyveld SF, Barth RE, Gras L, de Wolf F, Netea MG, Hoepelman AI. 
AIDS. 2013 Apr 24;27(7):1179-84. Epub 2012 Dec 31. Abstract

Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants 
Chiappini E, Galli L, Giaquinto C, Ene L, Goetghebuer T, Judd A, Lisi C, Malyuta R, Noguera-Julian A, Ramos JT, Rojo-Conejo P, Rudin C, Tookey P, de Martino M, Thorne C; European Pregnancy and Paediatric HIV Cohort Collaboration study group in EuroCoord.
AIDS. 2013 Mar 27;27(6):991-1000. doi: 10.1097/QAD.0b013e32835cffb1. Abstract

CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use 
Mocroft A, Phillips AN, Gatell J, Horban A, Ledergerber B, Zilmer K, Jevtovic D, Maltez F, Podlekareva D, Lundgren JD; EuroSIDA study in EuroCOORD.
AIDS. 2013 Mar 27;27(6):907-18. doi: 10.1097/QAD.0b013e32835cb766. Abstract

Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons. 
Rotger M, Glass TR, Junier T, Lundgren J, Neaton JD, Poloni ES, van 't Wout AB, Lubomirov R, Colombo S, Martinez R, Rauch A, Günthard HF, Neuhaus J, Wentworth D, van Manen D, Gras LA, Schuitemaker H, Albini L, Torti C, Jacobson LP, Li X, Kingsley LA, Carli F, Guaraldi G, Ford ES, Sereti I, Hadigan C, Martinez E, Arnedo M, Egaña-Gorroño L, Gatell JM, Law M, Bendall C, Petoumenos K, Rockstroh J, Wasmuth JC, Kabamba K, Delforge M, De Wit S, Berger F, Mauss S, de Paz Sierra M, Losso M, Belloso WH, Leyes M, Campins A, Mondi A, De Luca A, Bernardino I, Barriuso-Iglesias M, Torrecilla-Rodriguez A, Gonzalez-Garcia J, Arribas JR, Fanti I, Gel S, Puig J, Negredo E, Gutierrez M, Domingo P, Fischer J, Fätkenheuer G, Alonso-Villaverde C, Macken A, Woo J, McGinty T, Mallon P, Mangili A, Skinner S, Wanke CA, Reiss P, Weber R, Bucher HC, Fellay J, Telenti A, Tarr PE; MAGNIFICENT Consortium; INSIGHT; Swiss HIV Cohort Study.
Clin Infect Dis. 2013 Jul;57(1):112-21. doi: 10.1093/cid/cit196. Epub 2013 Mar 26. Abstract

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. 
Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing AM, Dewolf F, Nelson M, Montaner JS, Lane HC, Larder BA; on behalf of the RDI study group. 
J Antimicrob Chemother. 2013 Jun;68(6):1406-14. Epub 2013 Mar 13. Abstract

Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts 
Touloumi G, Pantazis N, Pillay D, Paraskevis D, Chaix ML, Bucher HC, Kücherer C, Zangerle R, Kran AM, Porter K; CASCADE collaboration in EuroCoord.
Clin Infect Dis. 2013 Mar;56(6):888-97. doi: 10.1093/cid/cis1000. Epub 2012 Dec 7. Abstract

Risk of tuberculosis following HIV seroconversion in high-income countries. 
Lodi S, del Amo J, d'Arminio Monforte A, Abgrall S, Sabin C, Morrison C, Furrer H, Muga R, Porter K, Girardi E; CASCADE collaboration in EuroCoord.
Thorax. 2013 Mar;68(3):207-13. doi: 10.1136/thoraxjnl-2012-201740. Epub 2012 Oct 31. Abstract

Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs study. 
Kovari H, Sabin CA, Ledergerber B, Ryom L, Worm SW, Smith C, Phillips A, Reiss P, Fontas E, Petoumenos K, De Wit S, Morlat P, Lundgren JD, Weber R.
Clin Infect Dis. 2013 Mar;56(6):870-9. doi: 10.1093/cid/cis919. Epub 2012 Oct 22. Abstract

Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe and the United States. 
The Antiretroviral Therapy Cohort Collaboration (ART-CC).
Clin Infect Dis. 2013 Jun;56(12):1800-9. Epub 2013 Mar 1. Abstract

Insurability of HIV positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies. 
Kaulich-Bartz J, Dam W, May MT, Lederberger B, Widmer U, Phillips AN, Grabar S, Mocroft A, Vilaro J, van Sighem A, Moreno S, Dabis F, Monforte AD, Teira R, Ingle SM, Sterne JA; Writing committee for the Antiretroviral Cohort Collaboration.
AIDS. 2013 Feb 25. [Epub ahead of print] Abstract

High incidence of intermittent care in HIV-1-infected patients in Curaçao before and after starting cART. 
Hermanides HS, Holman R, Gras L, Winkel CN, Gerstenbluth I, de Wolf F, Duits AJ.
AIDS Care. 2013 Feb 21. [Epub ahead of print] Abstract

An internationally generalizable risk index for mortality after one year of antiretroviral therapy. 
Tate JP, Justice AC, Hughes MD, Bonnet F, Reiss P, Mocroft A, Nattermann J, Lampe FC, Bucher HC, Sterling TR, Crane HM, Kitahata MM, May M, Sterne JA.
AIDS. 2013 Feb 20;27(4):563-72. doi: 10.1097/QAD.0b013e32835b8c7f. Abstract

Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. 
Ryom L, Mocroft A, Kirk O, Worm SW, Kamara DA, Reiss P, Ross M, Fux CA, Morlat P, Moranne O, Smith C, Lundgren JD; D:A:D Study Group.
J Infect Dis. 2013 May 1;207(9):1359-69. doi: 10.1093/infdis/jit043. Epub 2013 Feb 4. Abstract

Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events 
Monforte Ad, Reiss P, Ryom L, El-Sadr W, Dabis F, De Wit S, Worm SW, Law MG, Weber R, Kirk O, Pradier C, Phillips AN, Lundgren JD, Sabin CA.
AIDS. 2013 Jan 28;27(3):407-15. doi: 10.1097/QAD.0b013e32835b2ef1. Abstract

HIV-infected mental health patients: characteristics and comparison with HIV-infected patients from the general population and non-infected mental health patients. 
Schadé A, van Grootheest G, Smit JH.
BMC Psychiatry. 2013 Jan 23;13:35. doi: 10.1186/1471-244X-13-35. Abstract

Prolonged decrease of CD4+ T lymphocytes in HIV-1 infected patients after radiotherapy for a solid tumor. 
Sankatsing SU, Hillebregt MM, Gras L, Brinkman K, van der Ende M, de Wolf F, Stalpers LJ, Prins JM. 
J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):546-9. Epub Jan 10. Abstract

Predictors of CD4+ T-Cell Counts of HIV Type 1-Infected Persons After Virologic Failure of All 3 Original Antiretroviral Drug Classes. 
The Pursuing Later Treatment Option II (PLATO II) Project Team of the Collaboration of Observational HIV Epidemiological Research Europe (COHERE). 
J Infect Dis. 2013 Mar 1;207(5):759-67. Epub 2012 Dec 7. Abstract

Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997 
van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chêne G, Dorrucci M, Muga R, Porter K, Prins M; CASCADE Collaboration in EuroCoord.
Gastroenterology. 2013 Apr;144(4):751-760.e2. Epub 2012 Dec 22. Abstract

Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and N.America 2002-2009 
Abgrall S; The Antiretroviral Therapy Cohort Collaboration (ART-CC)
AIDS. 2013 Mar 13;27(50:803-13. Epub AIDS. 2012 Nov 28. Abstract


Rate of CD4 decline and HIV-RNA change following HIV Seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. 
Huang X, Lodi S, Fox Z, Li W, Phillips A, Porter K, Lutsar I, Kelleher A, Li N, Xu X, Wu H, Johnson AM; on behalf of the Beijing PRIMO cohort study and the CASCADE Collaboration in EuroCoord.
J Acquir Immune Defic Syndr. 2012 Dec 6. [Epub ahead of print] Abstract

Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. 
May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).
Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12. Abstract

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA 
D Grint, L Peters, M Vogel, M Beniowski, C Pradier, M Battegay, D Jevtovic, V Soriano, J Lundgren, J Rockstroh, O Kirk, A Mocroft
J Int AIDS Soc. 2012 Nov 11;15(6):18118. doi: 10.7448/IAS.15.6.18118. Abstract

Predicting the short-term risk of diabetes in HIV-positive patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. 
Petoumenos K, Worm SW, Fontas E, Weber R, De Wit S, Bruyand M, Reiss P, El-Sadr W, Monforte AD, Friis-Møller N, Lundgren JD, Law MG; D:A:D Study Group.
J Int AIDS Soc. 2012 Oct 10;15(2):17426. doi: 10.7448/IAS.15.2.17426. Abstract

The clinical benefits of antiretroviral therapy in severely immunocompromised HIV-1-infected patients with and without complete viral suppression. 
Mocroft A, Bannister WP, Kirk O, Kowalska JD, Reiss P, D'Arminio-Monforte A, Gatell J, Fisher M, Trocha H, Rakhmanova A, Lundgren JD; EuroSIDA Study in EuroCOORD.
Antivir Ther. 2012;17(7):1291-300. doi: 10.3851/IMP2407. Epub 2012 Sep 26. Abstract

Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study. 
Podlekareva DN, Reekie J, Mocroft A, Losso M, Rakhmanova AG, Bakowska E, Karpov IA, Lazarus JV, Gatell J, Lundgren JD, Kirk O; EuroSIDA study in EuroCoord.
BMC Infect Dis. 2012 Sep 25;12:229. doi: 10.1186/1471-2334-12-229. Abstract

Similar virologic response after initiation of triple-class antiretroviral therapy in primary and chronic HIV infection. 
Grijsen ML, Holman R, Wit FW, Gras L, Lowe SH, Brinkman K, de Wolf F, Prins JM.
AIDS. 2012 Sep 24;26(15):1974-7. Abstract

Could better tolerated HIV drug regimens improve patient outcome? 
Smit M, Smit C, Cremin I, Garnett GP, Hallett T, de Wolf F.
AIDS. 2012 Sep 24;26(15):1953-9. Abstract

Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. 
Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, Grzeszczuk A, Sambatakou H, Mocroft A, Kirk O; EuroSIDA in EuroCoord.
AIDS. 2012 Sep 24;26(15):1917-26. Abstract

Resurgence of HIV infection among men who have sex with men in Switzerland: mathematical modelling study. 
van Sighem A, Vidondo B, Glass TR, Bucher HC, Vernazza P, Gebhardt M, de Wolf F, Derendinger S, Jeannin A, Bezemer D, Fraser C, Low N; Swiss HIV Cohort Study.
PLoS One. 2012;7(9):e44819. Epub 2012 Sep 14. Abstract

Immunovirologic control 24 months after interruption of antiretroviral therapy initiated close to HIV seroconversion. 
Lodi S, Meyer L, Kelleher AD, Rosinska M, Ghosn J, Sannes M, Porter K.
Arch Intern Med. 2012 Sep 10;172(16):1252-5. doi: 10.1001/archinternmed.2012.2719 Abstract

Increasing sexual risk behaviour among Dutch men who have sex with men: mathematical models versus prospective cohort data. 
van Sighem A, Jansen I, Bezemer D, De Wolf F, Prins M, Stolte I, Fraser C.
AIDS. 2012 Sep 10;26(14):1840-3. doi: 10.1097/QAD.0b013e3283574df9. Abstract

The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. 
HIV-CAUSAL Collaboration.
AIDS. 2012 Aug 24;26(13):1691-705. Abstract

No advantage of quadruple- or triple-class antiretroviral therapy as initial treatment in patients with very high viraemia. 
Grijsen ML, Holman R, Gras L, Wit FW, Hoepelman AI, van den Berk GE, de Wolf F, Prins JM; ATHENA National Observational Cohort Study.
Antivir Ther. 2012;17(8):1609-13. doi: 10.3851/IMP2321. Epub 2012 Aug 22. Abstract

Time to virological failure, treatment change and interruption for individuals treated within 12 months of HIV seroconversion and in chronic infection. 
Zugna D, Geskus RB, De Stavola B, Rosinska M, Bartmeyer B, Boufassa F, Chaix ML, Babiker A, Porter K; CASCADE Collaboration in EuroCoord.
Antivir Ther. 2012;17(6):1039-48. doi: 10.3851/IMP2312. Epub 2012 Aug 15. Abstract

Effect of hepatitis C treatment on CD4+ T-cell counts and the risk of death in HIV-HCV-coinfected patients: the COHERE collaboration. 
HCV working group of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
Antivir Ther. 2012;17(8):1541-50. doi: 10.3851/IMP2263. Epub 2012 Jul 24. Abstract

Regional differences in AIDS and non-AIDS related mortality in HIV-positive individuals across Europe and Argentina: the EuroSIDA study. 
Reekie J, Kowalska JD, Karpov I, Rockstroh J, Karlsson A, Rakhmanova A, Horban A, Kirk O, Lundgren JD, Mocroft A; EuroSIDA in EuroCoord.
PLoS One. 2012;7(7):e41673. doi: 10.1371/journal.pone.0041673. Epub 2012 Jul 23. Abstract

Episodes of HIV viremia and the risk of non-AIDS diseases in patients on suppressive antiretroviral therapy. 
Zhang S, van Sighem A, Kesselring A, Gras L, Smit C, Prins JM, Kauffmann R, Richter C, de Wolf F, Reiss P.
J Acquir Immune Defic Syndr. 2012 Jul 1;60(3):265-72. doi: 10.1097/QAI.0b013e318258c651.Abstract

The clinical interpretation of viral blips in HIV patients receiving antiviral treatment: are we ready to infer poor adherence? 
Fung IC, Gambhir M, van Sighem A, de Wolf F, Garnett GP.
J Acquir Immune Defic Syndr. 2012 May 1;60(1):5-11. doi: 10.1097/QAI.0b013e3182487a20.Abstract

Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study. 
Grijsen M, Koster G, van Vonderen M, van Kasteren M, Kootstra G, Steingrover R, de Wolf F, Prins J, Nieuwkerk P; Primo-SHM study group.
HIV Med. 2012 Nov;13(10):630-5. doi: 10.1111/j.1468-1293.2012.01020.x. Epub 2012 Apr 25.Abstract

All-cause mortality in treated HIV-infected adults with CD4 ?500/mm3 compared with the general population: evidence from a large European observational cohort collaboration. 
Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G.
Int J Epidemiol. 2012 Apr;41(2):433-45. doi: 10.1093/ije/dyr164. Epub 2011 Nov 28. Abstract

HCV coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy. 
Snijdewind IJ, Smit C, Godfried MH, Nellen JF, de Wolf F, Boer K, van der Ende ME.
J Infect. 2012 Apr;64(4):409-16. doi: 10.1016/j.jinf.2011.12.012. Epub 2011 Dec 23. Abstract

Developing a multidisciplinary network for clinical research on HIV infection: the EuroCoord experience 
Frank de Wolf, Caroline Sabin, Ole Kirk, Claire Thorne, Genevieve Chene & Kholoud Porter. 
Clin. Invest. (2012) 2(3), 255–264 Article

Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. 
HIV-CAUSAL Collaboration.
Clin Infect Dis. 2012 May;54(9):1364-72. doi: 10.1093/cid/cis203. Epub 2012 Mar 28. Abstract

No Treatment versus 24 or 60 Weeks of Antiretroviral Treatment during Primary HIV Infection: The Randomized Primo-SHM Trial 
Grijsen ML, Steingrover R, Wit FW, Jurriaans S, Verbon A, Brinkman K, van der Ende ME, Soetekouw R, de Wolf F, Lange JM, Schuitemaker H, Prins JM; Primo-SHM Study Group.
PLoS Med. 2012;9(3):e1001196. Epub 2012 Mar 27. Abstract

CD4 Cell Count and the Risk of AIDS or Death in HIV-Infected Adults on Combination Antiretroviral Therapy with a Suppressed Viral Load: A Longitudinal Cohort Study from COHERE 
The Opportunistic Infections Project Team of the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord
PLoS Med. 2012 March; 9(3): e1001194. Published online 2012 March 20. doi: 10.1371/journal.pmed.1001194 Article

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa 
Pantazis N, Morrison C, Amornkul PN, Lewden C, Salata RA, Minga A, Chipato T, Jaffe H, Lakhi S, Karita E, Porter K, Meyer L, Touloumi G on behalf of CASCADE Collaboration in EuroCoord and ANRS 1220 Primo-CI Study Group. 
PLoS ONE 7(3): e32369. doi:10.1371/journal.pone.0032369 Abstract

Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe. 
Pursuing Later Treatment Options II (PLATO II) project team; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Group, Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A.
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):294-9. doi: 10.1097/QAI.0b013e31823fe66b.Abstract

Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. 
van Lelyveld SF, Gras L, Kesselring A, Zhang S, De Wolf F, Wensing AM, Hoepelman AI; ATHENA national observational cohort study.
AIDS. 2012 Feb 20;26(4):465-74. doi: 10.1097/QAD.0b013e32834f32f8. Abstract

Evaluation of HIV protease inhibitor use and the risk of sudden death or nonhemorrhagic stroke. 
Worm SW, Kamara DA, Reiss P, Fontas E, De Wit S, El-Sadr W, D'Arminio Monforte A, Law M, Phillips A, Ryom L, Dabis F, Weber R, Sabin C, Lundgren JD; D:A:D Study Group.
J Infect Dis. 2012 Feb 15;205(4):535-9. doi: 10.1093/infdis/jir788. Epub 2012 Jan 5. Abstract

The effect of injecting drug use history on disease progression and death among HIV-positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis. 
Murray M, Hogg RS, Lima VD, May MT, Moore DM, Abgrall S, Bruyand M, D'Arminio Monforte A, Tural C, Gill MJ, Harris RJ, Reiss P, Justice A, Kirk O, Saag M, Smith CJ, Weber R, Rockstroh J, Khaykin P, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).
HIV Med. 2012 Feb;13(2):89-97. doi: 10.1111/j.1468-1293.2011.00940.x. Epub 2011 Aug 7.Abstract

Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study. 
Pursuing Later Treatment Option II (PLATO II) project team; Observational HIV Epidemiological Research Europe (COHERE) Group, Castagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, Garcia F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Fabre-Colin C, Kjaer J, Grarup J, Costagliola D, Lodwick R, Ledergerber B, Phillips A.
Lancet Infect Dis. 2012 Feb;12(2):119-27. doi: 10.1016/S1473-3099(11)70248-1. Epub 2011 Oct 9.Abstract

Single nucleotide polymorphism in gene encoding transcription factor Prep1 is associated with HIV-1-associated dementia. 
Bol SM, Booiman T, van Manen D, Bunnik EM, van Sighem AI, Sieberer M, Boeser-Nunnink B, de Wolf F, Schuitemaker H, Portegies P, Kootstra NA, van 't Wout AB.
PLoS One. 2012;7(2):e30990. doi: 10.1371/journal.pone.0030990. Epub 2012 Feb 7. Abstract

Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy. 
Kowalska JD, Reekie J, Mocroft A, Reiss P, Ledergerber B, Gatell J, d'Arminio Monforte A, Phillips A, Lundgren JD, Kirk O; EuroSIDA study group.
AIDS. 2012 Jan 28;26(3):315-23. doi: 10.1097/QAD.0b013e32834e8805. Abstract

Is the virulence of HIV changing? A meta-analysis of trends in prognostic markers of HIV disease progression and transmission. 
Herbeck JT, Müller V, Maust BS, Ledergerber B, Torti C, Di Giambenedetto S, Gras L, Günthard HF, Jacobson LP, Mullins JI, Gottlieb GS.
AIDS. 2012 Jan 14;26(2):193-205. doi: 10.1097/QAD.0b013e32834db418. Abstract

The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI* 
Cozzi-Lepri A, Paredes, Phillips AN, Clotet B, Kjaer J, Von Wyl V, Kronborg G, Castagna A, Bogner JR, Lundgren JD; EuroSIDA in EuroCoord.
HIV Med. 2012 Jan;13(1):62-72. doi: 10.1111/j.1468-1293.2011.00943.x. Epub 2011 Aug 17.Abstract

Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. 
Jarrin I, Pantazis N, Gill MJ, Geskus R, Perez-Hoyos S, Meyer L, Prins M, Touloumi G, Johnson A, Hamouda O, de Olalla PG, Porter K, del Amo J; CASCADE Collaboration in EuroCoord.
Clin Infect Dis. 2012 Jan 1;54(1):111-8. doi: 10.1093/cid/cir814. Epub 2011 Nov 21. Abstract


Fatal and non-fatal AIDS and non-AIDS events in HIV-1 positive individuals with high CD4 counts according to viral load strata.
Reekie J, Gatell J, Yust I, Bakowska E, Rakhmanova A, Losso M, Krasnov M, Francioli P, Kowalska J, Mocroft A, for the EuroSIDA in EuroCoord.
AIDS. 2011 Nov 28;25:2259-68. Abstract 

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control. 

van Manen D, Gras L, Boeser-Nunnink BD, van Sighem AI, Maurer I, Mangas Ruiz MM, Harskamp AM, Steingrover R, Prins JM, de Wolf F, van 't Wout AB, Schuitemaker H; Dutch HIV monitoring foundation HIV-1 Host Genetics study.
AIDS. 2011 Nov 28;25(18):2217-26 Abstract 

Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study.
Mugavero MJ, May M, Ribaudo HJ, Gulick RM, Riddler SA, Haubrich R, Napravnik S, Abgrall S, Phillips A, Harris R, Gill MJ, de Wolf F, Hogg R, Günthard HF, Chêne G, D’arminio Monforte A, Guest JL, Smith C, Murillas J, Berenguer J, Wyen C, Domingo P, Kitahata MM, Sterne JA, Saag MS; on behalf of the AIDS Clinical Trial Group DACS 241 team AIDS Clinical Trial Group Study 5095 team AIDS Clinical Trial Group Study 5142 team and the Antiretroviral Cohort Collaboration.
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):253-60,  Epub ahead of print Aug 18. Abstract

The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy.

Boer K, Smit C, van der Flier M, de Wolf F; ATHENA cohort study group.

Eur J Public Health. 2011 Oct;21(5):632-7. Epub 2010 Nov 4.  Abstract

Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines.

Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, Porter K; on behalf of the CASCADE Collaboration in EuroCoord.

Clin Infect Dis. 2011 Oct;53(8):817-825. Abstract

An international collaboration to standardize HIV-2 viral load assays: Results from the 2009 ACHIEV2E quality control study.
Damond F, Benard A, Balotta C, Böni J, Cotten M, Duque V, Ferns B, Garson J, Gomes P, Gonçalves F, Gottlieb G, Kupfer B, Ruelle J, Rodes B, Soriano V, Wainberg M, Taieb A, Matheron S, Chene G, Brun-Vezinet F; for the ACHIEV2E Study group.

J Clin Microbiol. 2011 Oct;49(10):3491-7. Epub 2011 Aug 3. Abstract

Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.

Bailey H, Townsend C, Cortina-Borja M, Thorne C, European Collaborative Study in EuroCoord.

Antivir Ther. 2011;16(6):895-903. Abstract

The development of an expert system to predict virological response to HIV therapy as part of an on-line treatment support tool.

Revell AD, Wang D, Boyd MA, Emery S, Pozniak AL, De Wolf F, Harrigan PR, Montaner JS, Lane HC, Larder BA; on behalf of the RDI Study Group

AIDS. 2011 Sep 24;25(15):1855-1863. Epub 2011 Jul 21 Abstract

A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy.

Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, Bellido R, Betancor G, Bogner J, Gargalianos P, Bánhegyi D, Clotet B, Lundgren J, Menéndez-Arias L, Martinez-Picado J; The EuroSIDA Study Group.

J Infect Dis. 2011 Sep;204(5):741-752. Abstract

Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDA.

Fox ZV, Cozzi-Lepri A, D'Arminio Monforte A, Karlsson A, Phillips AN, Kronborg G, Kjaer J, Clotet B, Lundgren JD; EuroSIDA.

Antivir Ther. 2011;16(5):781-5. Abstract

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study.

Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, Friis-Møller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M; for the D:A:D Study Group.

HIV Med. 2011 Aug;12(7):412-421. Epub 2011 Jan 20 Abstract

Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.

Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O; EuroSIDA study group.

AIDS. 2011 Jul 31;25(12):1505-13. Abstract

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.

Jaffe HW, De Stavola BL, Carpenter LM, Porter K, Cox DR; CASCADE Collaboration.

AIDS. 2011 Jul 17;25(11):1395-403. Abstract

The Coding Causes of Death in HIV (CoDe) Project: Initial Results and Evaluation of Methodology.

Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C, Reiss P, Gill J, Lewden C, Phillips A, D'arminio Monforte A, Law M, Sterne J, De Wit S, Lundgren JD; for The CoDe Working Group and the D:A:D Study Group.

Epidemiology. 2011 Jul;22(4):516-523. Abstract

Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective.

Op de Coul EL, Hahne S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, Notermans DW, Boer K, Van der Sande MA.

BMC Infect Dis. 2011 Jun 30;11(1):185. Ned Tijdschr Geneeskd. 2010;154:A2175.

(In Dutch) Abstract 

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.

Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, Gatell J, Pedersen C, Bogner JR, Lundgren JD, Mocroft A; EuroSIDA Study Group.

AIDS. 2011 Jun 19;25(10):1305-15. Abstract

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes.

Bohlius J, Schmidlin K, Boué F, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Paparizos V, Miro JM, Obel N, Prins M, Chêne G, Egger M; Collaboration of Observational HIV Epidemiological Research Europe.

Blood. 2011 Jun 9;117(23):6100-8. Epub 2011 Mar 2. Abstract

The Efficacy of Combination Antiretroviral Therapy in HIV Type 1-Infected Patients Treated in Curaçao Compared with Antillean, Surinam, and Dutch HIV Type 1-Infected Patients Treated in The Netherlands.

Hermanides HS, Gras L, Winkel CN, Gerstenbluth I, van Sighem A, de Wolf F, Duits AJ.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):605-12. Epub 2010 Dec 14. Abstract

Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy.

Kesselring A, Gras L, Smit C, van Twillert G, Verbon A, de Wolf F, Reiss P, Wit F.

Clin Infect Dis. 2011 Jun;52(12):1458-65. Abstract

Quadruple antiretrovirale therapie heeft geen virologisch voordeel bij de behandeling van hiv-naïeve patiënten met een hoge plasma ‘virale load’. 
Grijsen ML, Holman R, Gras LAJ, de Wolf F, Prins JM, namens de ATHENA nationale observationele cohort studie
Tijdschrift voor Infectieziekten vol 6 nr. 4 2011(In Dutch)

Self-Reported Symptoms Among HIV-Infected Patients on Highly Active

Antiretroviral Therapy in the ATHENA Cohort in The Netherlands

de Boer M, Prins J.M, Sprangers M.A.G., Smit C, Nieuwkerk P.T.

HIV Clin Trials 2011;12(3):161–170 Abstract

HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV.

Lodwick R, Alioum A, Archibald C, Birrell P, Commenges D, Costagliola D, De Angelis D, Donoghoe M, Garnett G, Ghys P, Law M, Lundgren J, Ndawinz J, Presanis A, Sabin C, Salminen M, Sommen C, Stanecki K, Stover J, Supervie V, Sweeting M, van de Laar M, van Sighem A, Wand H, Wilson D, Yan P, Phillips A. Working Group on Estimation of HIV Prevalence in Europe.

AIDS. 2011 May 15;25(8):1017-23. Abstract

Risk of triple-class virological failure in children with HIV: a retrospective cohort study.

Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A.

Lancet. 2011 May 7;377(9777):1580-7. Epub 2011 Apr 20. Abstract 

Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2-Infected Patients: The ACHIEV2E Collaboration Study Group.

Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, Calmy A, Balotta C, Damond F, Brun-Vezinet F, Chene G, Matheron S

Clin Infect Dis. 2011 May;52(10):1257-1266. Abstract

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.

Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G; for the EuroCoord-CHAIN study group.

Lancet Infect Dis. 2011 May;11(5):363-371. Epub 2011 Feb 25. Abstract

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.

Reekie J, Reiss P, Ledergerber B, Sedlacek D, Parczewski M, Gatell J, Katlama C, Fätkenheuer G, Lundgren JD, Mocroft A; EuroSIDA study group.

HIV Med. 2011 May;12(5):259-68.  Epub 2010 Aug 31. Abstract

When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries: An Observational Study.

HIV-CAUSAL Collaboration, Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA.

Ann Intern Med. 2011 Apr 19;154(8):509-515. Abstract

A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.

Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O; Eurosida Study Group.

HIV Clin Trials. 2011 Mar-Apr;12(2):109-17. Abstract

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP, Kronborg G, Duiculescu D, Beniowski M, Machala L, Phillips A; EuroSIDA group.
J Antimicrob Chemother. 2011 Apr;66(4):901-11. Epub 2011 Jan 31. Abstract 

Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test.

Gras L, van Sighem A, Bezemer D, Smit C, Wit F, de Wolf F; ATHENA national observational cohort study.
AIDS. 2011 Mar 27;25(6):813-8. Abstract

Global trends in molecular epidemiology of HIV-1 during 2000-2007. Hemelaar J, Gouws E, Ghys PD, Osmanov S; WHO-UNAIDS Network for HIV Isolation and Characterisation.
AIDS. 2011 Mar 13;25(5):679-89. 

HIV Transmission Patterns among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study.
Kramer MA, Cornelissen M, Paraskevis D, Prins M, Coutinho RA, van Sighem AI, Sabajo L, Duits AJ, Winkel CN, Prins JM, van der Ende ME, Kauffmann RH, Op de Coul EL.
AIDS Res Hum Retroviruses. 2011 Feb;27(2):123-30. Epub 2010 Oct 7. Abstract

Adherence to HIV Therapeutic Drug Monitoring Guidelines in The Netherlands. van Luin M, Wit FW, Smit C, Rigter IM, Franssen EJ, Richter C, Kroon F, de Wolf F, Burger DM.
Ther Drug Monit. 2011 Feb;33(1):32-39. Abstract

National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools. 
Van Veen M, Presanis AM, Conti S, Xiridou M, Rinder Stengaard A, Donoghoe MC, van Sighem A, van der Sande MA, De Angelis D.
AIDS. 2011 Jan 14;25(2):229-37. Abstract